Wednesday, October 7, 2026
NewsezeNews with Rewards · Earn while you read
+5 credits / query
medicine

Detached Nails More Than 4 Times Higher Among GLP-1 Users, Study Finds

Newseze Wire·Wed, Oct 7, 6:12 PMWire: Healthline
Open original source Read full story (in-site)
Detached Nails More Than 4 Times Higher Among GLP-1 Users, Study Finds

In a new study, GLP-1 users reported nail detachment more than four times as often as nonusers. Waishaw/Getty Images GLP-1 drugs like Ozempic have been linked to unusual nail changes in a new study.

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis96 words · original commentary · full read loading…
In a new study, GLP-1 users reported nail detachment more than four times as often as nonusers. Waishaw/Getty Images GLP-1 drugs like Ozempic have been linked to unusual nail changes in a new study. The story falls into Newseze's medicine desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every hour and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: Healthline.
Ask Us · Any Story, Any AnswerBe the first to ask

Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.

No questions yet. Be the first.

Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.

Related stories

Increasing Ozempic Dose Linked to Lower Heart Risk Than Switching to Mounjaro
MEDICINEtrust 78
Increasing Ozempic Dose Linked to Lower Heart Risk Than Switching to Mounjaro

Why it mattersRecent research suggests that increasing your Ozempic dose may offer greater heart protection than switching to Mounjaro. Eva Kongshavn · Moment/Getty A real-world study found that people with type 2 diabetes who increas…

Recent research suggests that increasing your Ozempic dose may offer greater heart protection than switching to Mounjaro. Eva Kongshavn · Moment/Getty A real-wo…

ChellaBy Chella·32m ago
WireHealthline
Full Analysis Comment PostRead →
Switching from GLP-1 Injections to Wegovy Pill Shows Additional Weight Loss of 4.1%
MEDICINEtrust 72
Switching from GLP-1 Injections to Wegovy Pill Shows Additional Weight Loss of 4.1%

Why it mattersRecent research shows people who switch to the Wegovy pill from a GLP-1 injection can lose additional weight. PixelsEffect · E+/Getty People with overweight or obesity who switched from an injectable GLP-1 weight loss me…

Recent research shows people who switch to the Wegovy pill from a GLP-1 injection can lose additional weight. PixelsEffect · E+/Getty People with overweight or …

ChellaBy Chella·1h ago
WireHealthline
Full Analysis Comment PostRead →
Cutting Back on Ultra-Processed Foods May Help Ease Depression Symptoms
MEDICINEtrust 78
Cutting Back on Ultra-Processed Foods May Help Ease Depression Symptoms

Why it mattersRecent research has found that reducing UPF intake may help improve symptoms of depression. cafotodigital · E+/Getty A small study found that reducing ultra-processed food (UPF) intake was associated with improvements in…

Recent research has found that reducing UPF intake may help improve symptoms of depression. cafotodigital · E+/Getty A small study found that reducing ultra-pro…

ChellaBy Chella·3h ago
WireHealthline
Full Analysis Comment PostRead →
Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages
MEDICINEtrust 78
Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages

Why it mattersA new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Healthline/Photo by Eli Lilly A new analysis of previous studies f…

A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Health…

ChellaBy Chella·3h ago
WireHealthline
Full Analysis Comment PostRead →